Scolaris Content Display Scolaris Content Display

Intervenciones no farmacológicas para la prevención de la pérdida de puestos de trabajo en trabajadores con artritis inflamatoria

Contraer todo Desplegar todo

Referencias

References to studies included in this review

Allaire 2003 {published data only}

Allaire SH, Li W, LaValley MP. Reduction of job loss in persons with rheumatic diseases receiving vocational rehabilitation: a randomized controlled trial. Arthritis and Rheumatism 2003;48(11):3212‐8.

de Buck 2005 {published data only}

de Buck PD, le Cessie S, van den Hout WB, Peeters AJ, Ronday HK, Westedt ML, et al. Randomized comparison of a multidisciplinary job‐retention vocational rehabilitation program with usual outpatient care in patients with chronic arthritis at risk for job loss. Arthritis and Rheumatism 2005;53(5):682‐90.

Macedo 2009 {published data only}

Macedo AM, Oakley SP, Panayi GS, Kirkham BW. Functional and work outcomes improve in patients with rheumatoid arthritis who receive targeted, comprehensive occupational therapy. Arthritis and Rheumatism 2009;61(11):1522‐30.

References to studies excluded from this review

Abásolo 2007 {published data only}

Abásolo L, Carmona L, Hernández‐García C, Lajas C, Loza E, Blanco M, et al. Musculoskeletal work disability for clinicians: time course and effectiveness of a specialized intervention program by diagnosis. Arthritis and Rheumatism 2007;57(2):335‐42.

Fleten 2006 {published data only}

Fleten N, Johnsen R. Reducing sick leave by minimal postal intervention: a randomised, controlled intervention study. Occupational and Environmental Medicine 2006;63(10):676‐82.

Hammond 2004 {published data only}

Hammond A, Young A, Kidao R. A randomised controlled trial of occupational therapy for people with early rheumatoid arthritis. Annals of the Rheumatic Diseases 2004;63(1):23‐30.

Ince 2006 {published data only}

Ince G, Sarpel T, Durgun B, Erdogan S. Effects of a multimodal exercise program for people with ankylosing spondylitis. Physical Therapy 2006;86(7):924‐35.

Leon 2009 {published data only}

Leon L, Jover JA, Candelas G, Lajas C, Vadillo C, Blanco M, et al. Effectiveness of an early cognitive‐behavioral treatment in patients with work disability due to musculoskeletal disorders. Arthritis and Rheumatism 2009;61(7):996‐1003.

Masiero 2007 {published data only}

Masiero S, Boniolo A, Wassermann L, Machiedo H, Volante D, Punzi L. Effects of an educational‐behavioral joint protection program on people with moderate to severe rheumatoid arthritis: a randomized controlled trial. Clinical Rheumatology 2007;26(12):2043‐50.

Schlademan 2007 {published data only}

Schlademann S, Hüppe A, Raspe H. Results of a randomised controlled trial on the acceptance and the outcomes of a counselling on medical inpatient rehabilitation in gainfully employed members of statutory health insurances with rheumatoid arthritis. Gesundheitswesen 2007;69(6):6. [clinicaltrials.gov identifier NCT00229541]

Varekamp 2011 {published data only}

Varekamp I, Verbeek JH, de Boer A, van Dijk FJ. Effect of job maintenance training program for employees with chronic disease ‐ a randomized controlled trial on self‐efficacy, job satisfaction, and fatigue. Scandinavian Journal of Work Environment and Health 2011;37(4):288‐97.

References to ongoing studies

Carruthers 2014 {published and unpublished data}

Carruthers EC, Rogers P, Backman CL, Goldsmith CH, Gignac MA, Marra C, Village J, Li LC, Esdaile JM, Lacaille D. "Employment and arthritis: making it work" a randomized controlled trial evaluating an online program to help people with inflammatory arthritis maintain employment (study protocol).. BMC Med Inform Decis Mak 2014;14:59. [DOI: 10.1186/1472‐6947‐14‐59.; PUBMED: 25043631]

Keysor 2013 {unpublished data only}

Efficacy of a Modified Vocational Rehabilitation Intervention for Work Disability. Ongoing study Ongoing.

van Vilsteren 2012 {published data only}

van Vilsteren M, Boot CR, Steenbeek R, Schaardenburg D, Voskuyl AE, Anema JR. An intervention program with the aim to improve and maintain work productivity for workers with rheumatoid arthritis: design of a randomized controlled trial and cost‐effectiveness study. BMC Public Health 2012;12:496.

Allaire 2005

Allaire SH, Niu J, LaValley MP. Employment and satisfaction utcomes from a job retention intervention delivered to persons with chronic diseases. Rehabilitation Counselling Bulletin 2005;48(2):100‐9.

Allaire 2008

Allaire S, Wolfe F, Niu J, Zhang Y, Zhang B, LaValley M. Evaluation of the effect of anti‐tumor necrosis factor agent use on rheumatoid arthritis work disability: the jury is still out. Arthritis and Rheumatism 2008;59(8):1082‐9.

Anema 2009

Anema JR, Schellart AJ, Cassidy JD, Loisel P, Veerman TJ, van der Beek AJ. Can cross country differences in return‐to‐work after chronic occupational back pain be explained? An exploratory analysis on disability policies in a six country cohort study. Journal of Occupational Rehabilitation 2009;19(4):419‐26.

Braun 1998

Braun J, Bollow M, Remlinger G, Eggens U, Rudwaleit M, Distler A, et al. Prevalence of spondyloarthropathies in HLA‐B27 positive and negative blood donors. Arthritis and Rheumatism 1998;41(1):58‐67.

Brennan 1992

Brennan P, Silman A. Statistical methods for assessing observer variability in clinical measures. BMJ 1992;304(6840):1491–4.

Cohen 1960

Cohen J. A coefficient of agreement for nominal scales. Journal of Educational and Psychological Measurement 1960;20(1):37‐46.

Cohen 1988

Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd Edition. Hillsdale, New Jersey: Lawrence Erlbaum Associates, 1988.

Colebatch 2011

Colebatch AN, Marks JL, Edwards CJ. Safety of non‐steroidal anti‐inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis). Cochrane Database of Systematic Reviews 2011, Issue 11. [DOI: 10.1002/14651858.CD008872.pub2]

Dagfinrud 2008

Dagfinrud H, Kvien TK, Hagen KB. Physiotherapy interventions for ankylosing spondylitis. Cochrane Database of Systematic Reviews 2008, Issue 1. [DOI: 10.1002/14651858.CD002822.pub3]

de Boer 2011

de Boer AG, Taskila T, Tamminga SJ, Frings‐Dresen MH, Feuerstein M, Verbeek JH. Interventions to enhance return‐to‐work for cancer patients. Cochrane Database of Systematic Reviews 2011, Issue 2. [DOI: 10.1002/14651858.CD007569]

de Buck 2002

de Buck PD, Schoones JW, Allaire SH, Vliet Vlieland TP. Vocational rehabilitation in patients with chronic rheumatic diseases: a systematic literature review. Seminars in Arthritis and Rheumatism 2002;32(3):196‐203.

de Buck 2004

de Buck PD, Breedveld J, van der Giesen FJ, Vliet Vlieland TP. A multidisciplinary job retention vocational rehabilitation programme for patients with chronic rheumatic diseases: patients' and occupational physicians' satisfaction. Annals of the Rheumatic Diseases 2004;63(5):562‐8.

de Croon 2004

de Croon EM, Sluiter JK, Nijssen TF, Dijkmans BA, Lankhorst GJ, Frings‐Dresen MH. Predictive factors of work disability in rheumatoid arthritis: a systematic literature review. Annals of the Rheumatic Diseases 2004;63(11):1362‐7.

de Croon 2005

de Croon EM, Sluiter JK, Nijssen TF, Kammeijer M, Dijkmans BA, Lankhorst GJ, et al. Work ability of Dutch employees with rheumatoid arthritis. Scandinavian Journal of Rheumatology 2005;34(4):277‐83.

Deeks 2008

Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta‐analysis. In: Egger M, Davey Smith G, Altman DG editor(s). Systematic Reviews in Health Care: Meta‐Analysis in Context. 2nd Edition. London: BMJ Publishing Group, 2008:285‐312.

Duncan 1985

Duncan J, Hill DH. An investigation of the extent and consequences of measurement error in labor‐economic survey data. Journal of Labor Economics 1985;3(4):508‐32.

Escorpizo 2007

Escorpizo R, Bombardier C, Boonen A, Hazes JMW, Lacaille D, Strand V, et al. Worker productivity outcome measures in arthritis. Journal of Rheumatology 2007;34(6):1372‐80.

Fifield 1991

Fifield J, Reisine ST, Grady K. Work disability and the experience of pain and depression in rheumatoid arthritis. Social Science & Medicine 1991;33(5):579‐85.

Gabriel 2001

Gabriel SE. The epidemiology of rheumatoid arthritis. Rheumatic Disease Clinics of North America 2001;27(2):269‐81.

GRADE 2008 [Computer program]

Brozek J, Oxman A, Schünemann H. GRADEpro. Version 3.2 for Windows. GRADE working group, 2008.

Haafkens 2006

Haafkens J, Moerman C, Schuring M, van Dijk F. Searching bibliographic databases for literature on chronic disease and work participation. Occupational Medicine (Oxford, England) 2006;56(1):39‐45.

Higgins 2011

Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.

Hoving 2009

Hoving JL, Bartelds GM, Sluiter JK, Sadiraj K, Groot I, Lems WF, et al. Perceived work ability, quality of life, and fatigue in patients with rheumatoid arthritis after a 6‐month course of TNF inhibitors: prospective intervention study and partial economic evaluation. Scandinavian Journal of Rheumatology 2009;38(4):246‐50.

Hoving 2013

Hoving JL, van Zwieten MC, van der Meer M, Sluiter JK, Frings‐Dresen MH. Work participation and arthritis: a systematic overview of challenges, adaptations and opportunities for interventions. Rheumatology (Oxford) 2013;52(7):1254‐64.

Hurkmans 2009

Hurkmans E, van der Giesen FJ, Vliet Vlieland TP, Schoones J, Van den Ende EC. Dynamic exercise programs (aerobic capacity and/or muscle strength training) in patients with rheumatoid arthritis. Cochrane Database of Systematic Reviews 2009, Issue 4. [DOI: 10.1002/14651858.CD006853.pub2]

Khan 2009

Khan F, Ng L, Turner‐Stokes L. Effectiveness of vocational rehabilitation intervention on the return to work and employment of persons with multiple sclerosis. Cochrane Database of Systematic Reviews 2009, Issue 1. [DOI: 10.1002/14651858.CD007256.pub2]

Lacaille 2005

Lacaille D. Arthritis and employment research: where are we? Where do we need to go?. Journal of Rheumatology. Supplement 2005;72:42‐5.

Lacaille 2007

Lacaille D, White MA, Backman CL, Gignac MA. Problems faced at work due to inflammatory arthritis: New insights gained from understanding patients' perspectives. Arthritis and Rheumatism 2007;57(7):1269‐79.

Lefebre 2011

Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration. Available from www.cochrane‐handbook.org. The Cochrane Collaboration, Available from www.cochrane‐handbook.org., 2011.

MacKinnon 1992

MacKinnon JR. Occupational profiles: individuals with rheumatoid arthritis and a matched comparison sample. Work 1992;2:39‐49.

Mahalik 2006

Mahalik J, Shigaki CL, Baldwin D, Johnstone B. A review of employability and work site interventions for persons with rheumatoid arthritis and osteoarthritis. Work 2006;26(3):303‐11.

Mancuso 2000

Mancuso CA, Paget SA, Charlson ME. Adaptations made by rheumatoid arthritis patients to continue working: A pilot study of workplace challenges and successful adaptations. Arthritis Care and Research 2000;13(2):89‐99.

Mehnert 1990

Mehnert T, Krauss HH, Nadler R, Boyd M. Correlates of life satisfaction in those with disabling conditions. Rehabilitation Psychology 1990;35:3‐17.

Nilsson 2007

Nilsson I, Fitinghoff H, Lilja M. Continuing to work after the onset of rheumatoid arthritis. Work 2007;28:335‐42.

Radner 2012

Radner H, Ramiro S, Buchbinder R, Landewé RBM, van der Heijde D, Aletaha D. Pain management for inflammatory arthritis (rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and other spondyloarthritis) and gastrointestinal or liver comorbidity. Cochrane Database of Systematic Reviews 2012, Issue 1. [DOI: 10.1002/14651858.CD008951.pub2]

Ramiro 2011

Ramiro S, Radner H, van der Heijde D, van Tubergen A, Buchbinder R, Aletaha D, et al. Combination therapy for pain management in inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis). Cochrane Database of Systematic Reviews 2011, Issue 10. [DOI: 10.1002/14651858.CD008886.pub2]

RevMan 2011 [Computer program]

The Nordic Cochrane Centre. The Cochrane Collaboration. Review Manager (RevMan). Version 5.1. Copenhagen: The Nordic Cochrane Centre. The Cochrane Collaboration, 2011.

Riemsma 2003

Riemsma RP, Kirwan JR, Taal E, Rasker HJJ. Patient education for adults with rheumatoid arthritis. Cochrane Database of Systematic Reviews 2003, Issue 2. [DOI: 10.1002/14651858.CD003688]

Silva 2010

Silva KNG, Mizusaki Imoto A, Almeida GJM, Atallah ÁN, Peccin MS, Fernandes Moça Trevisani V. Balance training (proprioceptive training) for patients with rheumatoid arthritis. Cochrane Database of Systematic Reviews 2010, Issue 5. [DOI: 10.1002/14651858.CD007648.pub2]

Steultjens 2004

Steultjens EEMJ, Dekker JJ, Bouter LM, Schaardenburg DD, Kuyk MAMAH, Van den Ende ECHM. Occupational therapy for rheumatoid arthritis. Cochrane Database of Systematic Reviews 2004, Issue 1. [DOI: 10.1002/14651858.CD003114.pub2]

Straaton 1997

Straaton KV, Fine PR. Addressing work disability through vocational rehabilitation services. Bulletin on the Rheumatic Diseases 1997;46(3):1‐3.

ter Wee 2012

ter Wee MM, Lems WF, Usan H, Gulpen A, Boonen A. The effect of biological agents on work participation in rheumatoid arthritis patients: a systematic review. Annals of the Rheumatic Diseases 2012;71(2):161‐71.

Van der Meer 2011

Van der Meer M, Hoving JL, Vermeulen MI, Herenius MM, Tak PP, Sluiter JK, et al. Experiences and needs for work participation in employees with rheumatoid arthritis treated with anti‐tumour necrosis factor therapy. Disability and Rehabilitation 2011;33(25‐26):2587‐95.

Verbeek 2005

Verbeek J, Salmi J, Pasternack I, Jauhiainen M, Laamanen I, Schaafsma F, et al. A search strategy for occupational health intervention studies. Occupational and Environmental Medicine 2005;62(10):682‐7.

Verbeek 2012

Verbeek J, Ruotsalainen J, Hoving JL. Synthesizing study results in a systematic review. Scandinavian Journal of Work Environment and Health 2012;38(3):282‐90.

Verstappen 2007

Verstappen SM, Jacobs JW, Hyrich KL. Effect of anti‐tumor necrosis factor on work disability. Journal of Rheumatology 2007;34(11):2126‐8.

Vliet Vlieland 2009

Vliet Vlieland TP, de Buck PD, van den Hout WB. Vocational rehabilitation programs for individuals with chronic arthritis. Current Opinion in Rheumatology 2009;21(2):183‐8.

WHO 2001

World Health Organization. International classification of functioning, disability and health: ICF. World Health Organization, 2001.

Yelin 2003

Yelin E, Trupin L, Katz P, Lubeck D, Rush S, Wanke L. Association between etanercept use and employment outcomes among patients with rheumatoid arthritis. Arthritis and Rheumatism 2003;48(11):3046‐54.

Characteristics of studies

Characteristics of included studies [ordered by study ID]

Allaire 2003

Methods

RCT

Participants

Participants were employed people with a rheumatic disease who were at risk for job loss and resided in eastern Massachusetts. Participants were recruited through letters from rheumatologists.

Randomized: 242 participants, 122 in experimental group (I) and 120 in control group (C).

Baseline characteristics: female 81.2% vs 81.7%, overall 81%; age 50 (9.4) vs 49 (9.8), overall 49 (range 24 to 66); education beyond high school 39.2% vs 31.2%, overall 35% (n = 85); work type professional/managerial 35.2% vs 30.8%, overall 33% (n = 80); HAQ score functional limitation, mean 0.51(0.4) vs 0.57 (0.4), overall 0.54 (range 0‐1.7) judged as 'mild limitation' in patients with RA; IA 63.9% vs 62.5%. Type of rheumatic disease not provided, overall (in experimental and control group): RA (n = 142), OA (n = 53), SLE (n = 36), AS (n = 8), PsA (n = 3). Duration arthritis: unknown. All participants were either full time or part time employed and at 'work' at baseline, i.e. none were on either short term or long term disability leave (personal communication with first author). Previous job loss: unknown; previous sick leave: unknown.

Interventions

Intervention group: Job retention vocational rehabilitation provided by one of two rehabilitation counsellors during two 1.5‐hour sessions (or more) over a five‐month period. Intervention development was based on previous research findings and experience from rehabilitation counsellors. The intervention consisted of three components: (1) job accommodation, (2) vocational counselling and guidance, and (3) education and self‐advocacy.

  1. Job accommodation including an assessment of possible health‐related workplace barriers to job performance (e.g. difficulty handling objects, working the required number of hours or doing repetitive tasks) and development of solutions to the barriers identified by participants using an augmented version of the Work Experience Survey tool.

  2. In the vocational counselling / guidance component, the counsellor and participant evaluated the individual’s job in light of his or her rheumatic disease. If problems were foreseen, possible job alternatives, requirements, and relevant resources were identified. The counsellors conveyed positive messages about each participant's ability to work.

  3. In the education and self‐advocacy component, information about legal rights and responsibilities (such as the employee's responsibility to request accommodation when needed), guidance regarding disclosure issues, and skills training to increase the participant’s ability to request a job accommodation in an appropriate manner were provided.

The counsellors also gave the participants in the experimental group copies of pamphlets and flyers about how to manage health‐related employment problems and about other available resources.

Training professionals: The job retention vocational rehabilitation intervention was developed and delivered by one of two experienced rehabilitation counsellors employed by the study; both counsellors had several years of experience, but no particular expertise in job retention vocational rehabilitation.

Control group: Written information: Participants were given copies of the same pamphlets and flyers about how to manage health related employment problems and available resources that the experimental group participants received. These materials were mailed to the home addresses of the control group participants within one month after randomisation.

Outcomes

1) Job loss: follow‐up at 6 months intervals up to 48 months:

  • A) Time to job loss measured at 6‐month intervals (main outcome) over 48 months either being:

    • time to first temporary job loss event (at least two unemployment reports in 2 consecutive 6‐month intervals), or

    • time to first permanent job loss event (permanent disability or retirement as reported at each 6‐month follow‐up).

  • B) Time to permanent job loss event over 48 months (permanent disability or retirement as reported at each 6‐month follow‐up). Any job loss that occurred within the 48‐month period of follow‐up was counted.

  • C) Number of job loss events in 48 months

    • permanent and temporary job loss events combined,

    • permanent job loss,

    • temporary job loss.

Job loss could be due to all health or arthritis related reasons.

2) Sickness absenteeism: not reported

3) Work functioning: not reported

Notes

This study was run in a community setting.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

"Strata allocation lists were generated by the statistician and included in an Access database in such a way that treatment assignment was revealed only after a participant's characteristics were entered into the database." No further information regarding random sequence generation.

Allocation concealment (selection bias)

Low risk

See above: Using Access database, treatment assignment was revealed only after participants characteristics were entered in database.

Prognostic comparability baseline

Unclear risk

Baseline differences were minimal, though baseline information on sickness absenteeism was absent. HAQ scores were in same range (Table 1, Allaire 2003).

Blinding of participants and personnel (performance bias)
All outcomes

Low risk

Personal communication with first author: 16 August2013: "Patients were not told whether they had received either the experimental or control intervention; in enrolling subjects, patients were told we were testing two different ways of helping people stay employed. The counsellors provided intervention to experimental group subjects only and did not know or have any contact with control group subjects. Whether subjects told their work colleagues about their study participation remains doubtful." Employers were not involved in any way in Allaire's trial.

Blinding of outcome assessment (detection bias)
Job loss

Low risk

Personal communication with first author: 16 August 2013: "The researcher was blinded as to which subjects were in each group (she had little contact with any subjects – only brief contact with a few who called with a question when the research assistant was away)". Allaire 2005: "A professional data collector hired for the study collected the data by telephone." Overall the assessment of job loss was assessed by patients self report and judged low risk of bias.

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Allaire originally had a 36‐month follow‐up which was extended with an additional year of follow‐up. The main findings of this review are based on the outcomes of 12 and 24 months: in this time frame attrition was low. Recruitment was staggered and as a consequence not all participants were able to complete the 36 or 48 month follow‐up. During the original 36 months follow‐up 4 participants dropped out of the intervention group and 6 from the control group, and one patient died in each group. The total reported attrition rate one year later, at 48 months, by Allaire was 18% in the intervention and 20% in the control groups. Allaire reported that most of the drop outs were participants who choose not to participate in the additional year of follow‐up (up to 48 months).

Selective reporting (reporting bias)

Low risk

Study protocol is not available but given target of intervention ('job retention') and the primary outcome 'job loss' we consider reporting bias not likely.

Compliance

Unclear risk

Not documented in the trial text.

de Buck 2005

Methods

RCT

Participants

Participants were people with a paid job (full time or part time, on sick leave, or with partial disability pension) with chronic rheumatic disease (RA, AS, PA, other) with a self‐perceived disease‐related work problem threatening their ability to work. Participants were recruited at 11 hospital outpatient rheumatology departments near Leiden, The Netherlands.

Randomized: 140 participants, 74 in experimental group (I) and 66 in control group (C).

Baseline characteristics were: female 41 (55%) vs 38 (58%), age 43 (21 to 57) vs 44 (24 to 58); educational level High 15 (20%) Medium 37 (50%) Low 22 (30%) vs 10 (15%), 39 (59%) and 17 (26%); work type ‐ occupational category ‐ mental demands 20 (28%), mixed mental/physical demands 15 (20%), light physical demands 20 (27%), heavy physical demands 19 (25%) vs 24 (36%), 13 (20%), 19 (29%), 10 (15%); HAQ score (0‐3): 0.76 (0.50) vs 0.83 (0.55); type of rheumatic disease, RA 34 (46%) vs 36 (55%), AS PA or reactive arthritis 17(23) vs 12 (18), SLE or scleroderma 23 (31%) vs 18 (27%). Duration disease: median (range) 11.0(0‐158) vs 19.5(0‐174). Full time or part time employment: unknown; previous job loss: unknown; sick leave: 42(57%) vs 35 (53%), duration sick leave median weeks (range) 16 (1‐52) vs 18 (3‐48); partial work disability benefit 12 (16%) vs 11 (17%). Adaptation at work due to rheumatic disease 22(29%) vs 15 (23%).

Interventions

Experimental group: Hospital‐based multidisciplinary vocational rehabilitation programme ran by a multi‐disciplinary team (rheumatologist, social worker, physical therapist, occupational therapist and psychologist) during 4 to 12 weeks. During the intervention period participants visited Leiden University Medical Center, the Netherlands at least twice in connection with the rehabilitation program, which always consisted of a systematic assessment and a discussion with the team coordinator:

  • Systematic assessment: The participants first visit consisted of a systematic assessment by two hospital professionals:

    • assessment by the rheumatologist (disease activity, joint destruction, extraarticular manifestations,severity activity limitations, prognosis regarding future impairments and activity limitations)

    • assessment by the coordinator, i.e. a physical therapist or social worker (education level, previous jobs; systematic registration of the problems in working situation, using a list of potential challenges and psychosocial situations). Other additional team members could also be consulted to evaluate the work situation.

  • Optional: education, counselling or treatment: Depending on the specific problems of the individual patient the intervention consisted of:

    • education (such as providing written and oral information about the Dutch social security system regarding sick leave and work disability),

    • counselling and guidance (such as the identification of resources for adapting the work environment or work hours, promotion of work self efficacy), or

    • treatment (such as adaptation of the medical treatment in consultation with the referring rheumatologist, exercise therapy, occupational therapy, functional training of relevant activities or mental restoration). It was found that except for rheumatologist visits (slightly more visits in control group) the mean number of visits to professionals (the rheumatology nurse specialist, occupational therapist, physical therapist, social worker, psychologist or the occupational physician) both during the intervention period and follow‐up, were not significantly different between the experimental and control group.

  • Discussion with team coordinator: The patient and team coordinator (physical therapist or social worker) discussed a report produced by the multi‐disciplinary team (also attended by hospital occupational physician in an advisory role) which included all information about the current disease characteristics and prognosis, the work situation, description of work problems, and the counselling or treatment options given by team members.

The final report was then sent to the rheumatologist who referred the patient and was sent to the participants' (company) occupational physician, but only if the patient had given written informed consent.

Control group: Usual outpatient care: participants were treated and referred to other health professionals in relation to their working problem if regarded necessary by their rheumatologist. In addition, all participants received the same written information about the Dutch social security system regarding sick leave and work disability as participants in the experimental group.

In both experimental and control groups, physicians had free choice with respect to their medical prescriptions and other treatment strategies. All medical treatment and the use of health services during the intervention period and two‐year follow‐up were recorded in both groups.

Outcomes

1) Job loss:

  • A) occurrence of job loss (official work disability pension or unemployment) measured using participants records of their work status at each follow‐up visit.

  • B) the number of participants whose extent of disability pension had increased (by receiving an official full disability pension or by receiving a new or a larger official partial disability pension) recorded at every time point.

2) Sickness absenteeism: not reported

3) Work functioning: not reported

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

"Randomization was done with stratification for center (academic hospital versus nonacademic hospital) and 3 diagnosis groups (RA; AS, psoriatic arthritis, or reactive arthritis; and SLE or scleroderma), according to a randomisation list that was created by a random digit generator."

Allocation concealment (selection bias)

Unclear risk

Not clearly documented in the text of the study.

Prognostic comparability baseline

Low risk

Some imbalance in number of participants with long sick leave > 40 weeks: n = 6 (8%) in the intervention group, and n = 2 (3%) in the control group (difference p = 0.17). Other sick leave variables measured at baseline were similar. Overall we judged differences to have a low risk of bias.

Blinding of participants and personnel (performance bias)
All outcomes

High risk

"To maintain allocation concealment, patients were instructed not to inform the principal investigator or the research nurse about the type of care they received." However, participants received many interventions in the control group as prescribed by the participating rheumatologists who were not blinded. de Buck 2005: "Moreover, the rheumatologist was informed about the treatment allocation in a later stage, another factor that could have induced enhanced treatment or referrals in connection with the work problem in the usual care (UC) group. Indeed, participants in the UC group initially paid more visits to the rheumatologist than participants in the Vocational Rehabilitation (VR) group. The participants' participation in the trial could have made rheumatologists aware of their participants' problems at work, and if a patient was allocated to the UC group rheumatologists might have thought they needed to act on account of their patients. In addition, it is possible that participants who were allocated to the control group made an extra appointment with their rheumatologist to discuss their working problem and potential solutions." Considering the high referral rate in the control group we think the contrast between treatment groups diminished (towards no effect), hence we judged high risk of bias.

Blinding of outcome assessment (detection bias)
Job loss

Low risk

See above. The assessment of job loss was assessed by participants' self report and judged low risk of bias.

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Loss to follow‐up accounted for (total 25/140: 13/74 in intervention group and 12/66 in control group) 18% at 24 months and was fairly evenly distributed between experimental and control group. In addition, baseline characteristics distribution of non‐completers were similar.

Selective reporting (reporting bias)

Low risk

Study protocol is not available but given target of intervention ('vocational rehabilitation'), primary outcome 'job loss' and the non‐significant results we consider reporting bias not likely.

Compliance

Low risk

We judged compliance as low risk of bias even though few participants were seen by their companies' occupational physician and did not receive additional guidance.

Macedo 2009

Methods

RCT

Participants

Participants were employed patients with RA and medium to high work disability risk (assessed by RA WIS) who were recruited from RA Centre clinics in London, UK.

Randomized: 32 participants, 16 in experimental group (I) and 16 in control group (C).

Baseline characteristics: female 15 vs 15; age 49 (12) vs 53 (8); educational level college/university 10 vs 8, postgraduate 2 vs 0; work type: occupational category ‐ managers and professionals 11 vs 10, administrative and skilled trades 5 vs 4, customer service and sales 0 vs 2. Full time work 15 (94%) vs 9 (56%); Job duration < 1 year 3 vs 2, 1 to 3 years 4 vs 1, 3 to 5 years 1 vs 1, > 5 years 8 vs 12; HAQ DI score 1.36 (0.84) vs 1.39 (0.46); Duration disease: median (range) 11.6 (9.9) vs 8.4(6.2).

Previous job loss: unknown; days (in month) missed from work, 3.3 (6.2) vs 2.1 (5.0). Biologic agents 2 vs 3 (all other on DMARDs).

Interventions

Experimental group: Comprehensive occupational therapy provided by one occupational therapist (OT) specialized in rheumatology and vocational rehabilitation for a maximum duration of 6 months for 6 to 8 individualized treatment sessions lasting 30 minutes to 2 hours either in groups or individually, including work visits. Usual rheumatology care was provided as well. The case management role of the OT incorporated a biopsychosocial model stemming from the Canadian Occupational Performance Measure (COPM).

  • Assessment: this included a work assessment and a functional assessment, in addition to an assessment of the patient’s medical history, and a psychosocial assessment followed by an individualized treatment plan.

  • Occupational therapy interventions: 6 to 8 sessions by one OT within the rheumatology or occupational therapy department, the home or the workplace lasting between 30 minutes to 2 hours, either in groups (education program was followed by 6 participants) or individually; work visits required the greatest amount of time.

    • Typical interventions included provision of education on RA, medications, compliance and management within the RA Centre clinics, self‐advocacy, workplace rights and responsibilities, ergonomic reviews, discussions with employers regarding reasonable accommodations, posture advice, pacing, activities of daily living, stress management, assertiveness, sleep posture and hygiene, exercises, footwear, splinting and assertive communication. Seven participants received a workplace visit.

  • Referrals: Participants were referred to multidisciplinary team members and community services as required.

Control group: Usual care in the RA Centre clinics involved routine reviews by the rheumatologist. The focus of treatment was on early, aggressive medical management with a goal of achievement of remission (DAS28 score 2.6). There was no OT involvement with these participants. Medical management and rheumatology clinic visit schedules were not changed from normal practice for either group.

Outcomes

1) Job loss: None reported

2) Sickness absenteeism due to illness/RA:

  • A. Workdays missed per month

  • B. Days missed/days worked per month, %

The instrument was a self‐developed Modified Health Economics Questionnaire combined measures of presenteeism and absenteeism. This is a written self‐report questionnaire that includes the number of days/hours spent at work per week, the number of days missed from work in the past month due to RA.

3) Work functioning:

  • C. RA‐WIS: measured at baseline and 6 months. Counting all yes responses resulted in a score range between 0 and 23. A higher score indicates a higher risk of work disability. Based on the scoring criteria, the medium work disability risk group was indicated by a score 10 but 17, and the high work disability risk group by a score 17. Participants who moved from a medium‐ or high‐risk group to a low‐risk group were identified according to the above criteria.

Notes

See text publication: under "occupational therapy received" page 1525: the COPM was used as an outcome measure but its outcomes were also used to direct the intervention. It's unclear whether this could bias participants in the intervention group.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

No information on random sequence generation.

Allocation concealment (selection bias)

Low risk

"Patients were stratified into medium‐risk (RA WIS score 10 and 17) or high‐risk (RA WIS score 17) groups. Then within these strata, patients were randomly allocated in equal numbers to the occupational therapy or usual care group. The allocation procedure was completed in a blinded manner by an independent research nurse, using a sealed envelope method."

Prognostic comparability baseline

High risk

Some questions can be made about the prognostic comparability of both groups. As the group size is small with only 16 participants per group, little differences in prognosis can have substantial influence on outcome. Differences that may count are: longer disease duration in experimental group; more workers with full time employment in the experimental group; more university postgraduates in experimental group; younger people in experimental group. Regardless of whether these differences are significant or not, these factors could have a relationship with both the intervention and the outcome 'work days missed'. The analyses do not account for differences in prognostic imbalances (other outcomes did, but not workdays missed): independent samples T‐tests have been done for the work related outcomes. In addition, using T‐tests for skewed data like work absenteeism (workdays missed) is probably not adequate as well, especially if sample size is small.

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Potentially personnel, the participants or the participants work colleagues were more aware or willing to support or influence the participants' work status, as a consequence of belonging to the experimental group or control group but for this trial we have no information that this happened. The extent of this effect remains unclear.

Blinding of outcome assessment (detection bias)
Sickness absenteeism

High risk

"self‐report questionnaire that includes the number of days/hours spent at work per week, the number of days missed from work in the past month due to RA." We consider these self report data to have a high risk of bias, and not be an objective measure. The intervention was quite intensive with 6 months of comprehensive OT including workplace visits which may have influenced patients recall at the six‐month follow‐up. Certainly there would be more emphasis on the importance of job loss or taking sick leave, although it is not clear how big this effect would be in either group.

Blinding of outcome assessment (detection bias)
Work functioning

Low risk

The outcome used, the RA WIS is a "self‐administered, written, validated questionnaire used to screen for work disability" and was assessed by patients' self report and judged low risk of bias.

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Macedo reports the same number of participants at baseline and 6 months, and reports no job loss during the 6 months follow‐up.

Selective reporting (reporting bias)

Low risk

Study protocol is not available but given target of intervention ('targeted comprehensive Occupational Therapy" and participants with "with perceived work disability risk" ) and the primary outcome work productivity we consider reporting bias not likely.

Compliance

Unclear risk

No information is provided on the control group. Little information is provided for experimental group on the number of sessions of OT sessions. Not all attended group sessions or received work visits, and the type of interventions was highly variable. We considered the risk (and direction) of bias unclear. Macedo 2009: "half had a work visit completed and recommendations provided to their employer" and "Most patients (n=15) had approximately 6–8 occupational therapy sessions (30–120 minutes) to review work, home, and social needs on a one‐to‐one basis or in a group format. The remaining patient had a single consultation session due to poor attendance. Six patients attended the group education program run by the OT."

RA: rheumatoid arthritis, AS: ankylosing spondylitis, OA: osteoarthritis, PsA: psoriatic arthritis, SLE: systemic lupus erythematosus

Characteristics of excluded studies [ordered by study ID]

Study

Reason for exclusion

Abásolo 2007

Not sufficient participants with IA.

Intervention does not fulfill all criteria.

Fleten 2006

Not sufficient participants with IA.

Hammond 2004

Intervention does not fulfill all criteria.

No work‐related outcome.

Sub‐population not working (some retired).

Ince 2006

Intervention does not fulfill all criteria.

No work‐related outcome.

Leon 2009

Not sufficient participants with IA.

Intervention does not fulfill all criteria.

Masiero 2007

Intervention does not fulfill all criteria.

No work‐related outcome.

Schlademan 2007

Intervention does not fulfill all criteria.

Varekamp 2011

Not sufficient participants with IA.

Characteristics of ongoing studies [ordered by study ID]

Carruthers 2014

Trial name or title

“Employment and arthritis: making it work”‐ a randomized controlled trial evaluating an online program to help people with inflammatory arthritis maintain employment

Methods

RCT of the making it work program compared to usual care and receiving printed information about arthritis and employment

Participants

Employed people, aged 18‐59, with inflammatory arthritis (RA, AS,PsA or SLE with arthritis) , at risk of job loss

Interventions

The intervention consists of a) 5 online group sessions; b) 5 web‐based e‐learning modules; c) consultations with an occupational therapist for an ergonomic assessment of their work and with a vocational rehabilitation counselor for job retention vocational counselling.

Outcomes

Primary outcomes include at‐work productivity (presenteeism)and work cessation (define as stopping work for > 6 months for any reason). Secondary outcomes include temporary work cessation, number of days missed from work per year, reduction in hours worked per week. A cost‐utility analysis of the intervention will also be performed, from a societal perspective

Starting date

September 2013

Contact information

Diane Lacaille: [email protected]

Notes

Trial registration NCT01852851

Keysor 2013

Trial name or title

Efficacy of a Modified Vocational Rehabilitation Intervention for Work Disability

Methods

RCT

Participants

Employed persons with rheumatoid and other forms of arthritis, as well as other rheumatic conditions

Interventions

Job retention delivered by physical and occupational therapists. Intervention has similarity to that in Allaire 2003. Control group: printed materials concerning working with a disability and relevant resources.

Outcomes

Ability to work, satisfaction with ability to work, job loss.

Starting date

Ongoing

Contact information

Julie Keysor: [email protected]

Notes

US

van Vilsteren 2012

Trial name or title

"Care for Work" study

Methods

RCT

Participants

The population consists of RA patients (18 to 64 years of age) who have visited a rheumatologist of one of the participating hospitals during the last year. Eligible patients are diagnosed with RA, and have a paid job (paid‐employment or self‐employed) for at least 8 hours per week. Furthermore, eligible patients experience difficulties in functioning at work.

Interventions

The intervention program consists of two components which complement each other; integrated care including a participatory workplace intervention.

Outcomes

The primary outcome measure is work productivity, measured by hours lost from work due to presenteeism. Secondary outcome measures include sick leave, quality of life, pain and fatigue. Cost‐effectiveness of the intervention program will be evaluated from the societal perspective.

Starting date

2012, first results 2015

Contact information

Myrthe van Vilsteren: [email protected]

Notes

Trial registration NTR2886

RA: rheumatoid arthritis, AS: ankylosing spondilitis, OA: osteoarthritis, PsA: psoriatic arthritis, SLE: systemic lupus erythematosus

Data and analyses

Open in table viewer
Comparison 1. job loss prevention vs control intervention

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Job loss counts (workers) cumulative 12, 24, 30, 48 months Show forest plot

2

Risk Ratio (M‐H, Random, 95% CI)

Totals not selected

Analysis 1.1

Comparison 1 job loss prevention vs control intervention, Outcome 1 Job loss counts (workers) cumulative 12, 24, 30, 48 months.

Comparison 1 job loss prevention vs control intervention, Outcome 1 Job loss counts (workers) cumulative 12, 24, 30, 48 months.

1.1 Follow‐up 12 months

2

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

1.2 Follow‐up 24 months

2

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

1.3 Follow‐up 30 months

1

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

1.4 Follow‐up 48 months

1

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

2 Sickness absenteeism ‐ work days missed per month ‐ six months Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

Analysis 1.2

Comparison 1 job loss prevention vs control intervention, Outcome 2 Sickness absenteeism ‐ work days missed per month ‐ six months.

Comparison 1 job loss prevention vs control intervention, Outcome 2 Sickness absenteeism ‐ work days missed per month ‐ six months.

3 Work functioning ‐ RA WIS ‐ six months Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

Analysis 1.3

Comparison 1 job loss prevention vs control intervention, Outcome 3 Work functioning ‐ RA WIS ‐ six months.

Comparison 1 job loss prevention vs control intervention, Outcome 3 Work functioning ‐ RA WIS ‐ six months.

4 Extra: Job loss or increase in disability pension: counts (participants) ‐ 24 months Show forest plot

1

Risk Ratio (M‐H, Fixed, 95% CI)

Totals not selected

Analysis 1.4

Comparison 1 job loss prevention vs control intervention, Outcome 4 Extra: Job loss or increase in disability pension: counts (participants) ‐ 24 months.

Comparison 1 job loss prevention vs control intervention, Outcome 4 Extra: Job loss or increase in disability pension: counts (participants) ‐ 24 months.

5 Extra: Job loss events ‐ permanent and temporary ‐ 48 months Show forest plot

1

Risk Ratio (M‐H, Fixed, 95% CI)

Totals not selected

Analysis 1.5

Comparison 1 job loss prevention vs control intervention, Outcome 5 Extra: Job loss events ‐ permanent and temporary ‐ 48 months.

Comparison 1 job loss prevention vs control intervention, Outcome 5 Extra: Job loss events ‐ permanent and temporary ‐ 48 months.

6 Extra: Sickness absenteeism ‐ Workdays missed as proportion of days worked over the past month ‐ six months Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

Analysis 1.6

Comparison 1 job loss prevention vs control intervention, Outcome 6 Extra: Sickness absenteeism ‐ Workdays missed as proportion of days worked over the past month ‐ six months.

Comparison 1 job loss prevention vs control intervention, Outcome 6 Extra: Sickness absenteeism ‐ Workdays missed as proportion of days worked over the past month ‐ six months.

Study flow diagram.
Figuras y tablas -
Figure 1

Study flow diagram.

Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included trials.
Figuras y tablas -
Figure 2

Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included trials.

Risk of bias summary: review authors' judgements about each risk of bias item for each included trial.
Figuras y tablas -
Figure 3

Risk of bias summary: review authors' judgements about each risk of bias item for each included trial.

Comparison 1 job loss prevention vs control intervention, Outcome 1 Job loss counts (workers) cumulative 12, 24, 30, 48 months.
Figuras y tablas -
Analysis 1.1

Comparison 1 job loss prevention vs control intervention, Outcome 1 Job loss counts (workers) cumulative 12, 24, 30, 48 months.

Comparison 1 job loss prevention vs control intervention, Outcome 2 Sickness absenteeism ‐ work days missed per month ‐ six months.
Figuras y tablas -
Analysis 1.2

Comparison 1 job loss prevention vs control intervention, Outcome 2 Sickness absenteeism ‐ work days missed per month ‐ six months.

Comparison 1 job loss prevention vs control intervention, Outcome 3 Work functioning ‐ RA WIS ‐ six months.
Figuras y tablas -
Analysis 1.3

Comparison 1 job loss prevention vs control intervention, Outcome 3 Work functioning ‐ RA WIS ‐ six months.

Comparison 1 job loss prevention vs control intervention, Outcome 4 Extra: Job loss or increase in disability pension: counts (participants) ‐ 24 months.
Figuras y tablas -
Analysis 1.4

Comparison 1 job loss prevention vs control intervention, Outcome 4 Extra: Job loss or increase in disability pension: counts (participants) ‐ 24 months.

Comparison 1 job loss prevention vs control intervention, Outcome 5 Extra: Job loss events ‐ permanent and temporary ‐ 48 months.
Figuras y tablas -
Analysis 1.5

Comparison 1 job loss prevention vs control intervention, Outcome 5 Extra: Job loss events ‐ permanent and temporary ‐ 48 months.

Comparison 1 job loss prevention vs control intervention, Outcome 6 Extra: Sickness absenteeism ‐ Workdays missed as proportion of days worked over the past month ‐ six months.
Figuras y tablas -
Analysis 1.6

Comparison 1 job loss prevention vs control intervention, Outcome 6 Extra: Sickness absenteeism ‐ Workdays missed as proportion of days worked over the past month ‐ six months.

Summary of findings for the main comparison. Job loss prevention compared to control intervention in people with inflammatory arthritis

Job loss prevention compared to control intervention in people with IA

Patient or population: people with IA
Settings:
Intervention: job loss prevention
Comparison: control intervention consisting of usual care or information

Outcomes

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No of participants
(trials)

Quality of the evidence
(GRADE)

Comments

Assumed risk

Corresponding risk

Control intervention 7

Job loss prevention

Job loss
Self report by questionnaire
Follow‐up: mean 24 months

See comment

See comment

Not estimable

340
(2 trials)

⊕⊝⊝⊝
very low1,2,3,4

Due to inconsistency in the trials we did not pool these two trials

Sickness absenteeism
Self reported no workdays missed in past month. Scale from: 0 to 22.
Follow‐up: mean 6 months

The mean sickness absenteeism in the control groups was
2.75 days absent

The mean sickness absenteeism in the intervention groups was
2.42 lower
(5.03 lower to 0.19 higher)

32
(1 study)

⊕⊝⊝⊝
very low5,6

Work functioning
Rheumatoid Arthritis Work Instability Scale. Scale from: 0 to 23 (higher score = worse work functioning)
Follow‐up: mean 6 months

The mean work functioning in the control groups was
13.67 score points

The mean work functioning in the intervention groups was
4.67 lower
(8.43 to 0.91 lower)

32
(1 study)

⊕⊝⊝⊝
very low5,6

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% CI) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval;

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

1 We judged the RCTs by de Buck 2005 and Macedo 2009 to have an overall high risk of bias and the RCT by Allaire 2003 to have an overall low risk of bias. Overall, we judged serious risk of bias to be present and therefore we downgraded the quality of the evidence by one level (‐1).
2 The magnitude of the effect on job loss for Allaire 2003 and de Buck 2005 show different relative risks. Allaire 2003 cites a highly significant and large beneficial effect (24 months: RR 0.35, 95% CI 0.18 to 0.68) whereas de Buck 2005 shows no effect (RR 1.05, 95% CI 0.53 to 2.06). The CIs hardly overlap. In addition, considerable statistical heterogeneity is present (I2 > 80%). Hence we did not pool the results. As we failed to identify a plausible explanation for the inconsistency, we downgraded the quality of the evidence by two levels (‐2). For the outcomes sickness absenteeism and work functioning, we only had one included RCT. Hence we judged inconsistency as not serious.
3 The number of job loss events was less than 300. The 'threshold rule of thumb value' states that there should be at least 300 events for job loss (dichotomous outcome), and for continuous outcomes there should be at least 400 participants (Higgins 2011). None of the trials fulfilled this criterion, nor did any of the comparisons for any of the outcomes. As the two RCTs reporting on job loss (Allaire 2003; de Buck 2005) were considerably larger than the one very small study (Macedo 2009) we judged the two to have serious imprecision, and so we downgraded the quality of the evidence by just one level (‐1).
4 We included both trials with smaller (N = 32 in Macedo 2009) and larger (N = 140 in de Buck 2005, N = 242 in Allaire 2003) sample sizes and both trials with positive (Allaire 2003 ; Macedo 2009) as well as non‐significant results (de Buck 2005). Given the low number of trials we were unable to further analyse publication bias with funnel plots or with statistical tests. Consequently we did not downgrade the quality of the evidence.
5 Risk of bias in the Macedo 2009 RCT related in particular to an absence of prognostic comparability and blinding of outcome assessment, which we judged to be sources for serious risk of bias. Consequently we downgraded the quality of the evidence by one level (‐1).
6Macedo 2009 included only 32 participants in total. We considered it to have very serious imprecision for the outcomes sickness absenteeism and work functioning. Thus we downgraded the quality of the evidence by two levels (‐2).

7 All control groups received either usual care or a minimal intervention such as written information in Allaire 2003.

Figuras y tablas -
Summary of findings for the main comparison. Job loss prevention compared to control intervention in people with inflammatory arthritis
Table 1. Other outcome data reported in the RCTs

Outcome measures

Follow‐up times

Trials

Extra analyses

Combined job loss or increase of disability pension

24 months

de Buck 2005

Analysis 1.4

Job loss events

48 months

Allaire 2003

Analysis 1.5

Sickness absenteeism defined as workdays missed in proportion to days worked

Macedo 2009

Analysis 1.6

In this table we present other supporting job loss outcome data reported in the trials for informative purposes only. These data do not contribute to our conclusions.

Figuras y tablas -
Table 1. Other outcome data reported in the RCTs
Comparison 1. job loss prevention vs control intervention

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Job loss counts (workers) cumulative 12, 24, 30, 48 months Show forest plot

2

Risk Ratio (M‐H, Random, 95% CI)

Totals not selected

1.1 Follow‐up 12 months

2

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

1.2 Follow‐up 24 months

2

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

1.3 Follow‐up 30 months

1

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

1.4 Follow‐up 48 months

1

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

2 Sickness absenteeism ‐ work days missed per month ‐ six months Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

3 Work functioning ‐ RA WIS ‐ six months Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

4 Extra: Job loss or increase in disability pension: counts (participants) ‐ 24 months Show forest plot

1

Risk Ratio (M‐H, Fixed, 95% CI)

Totals not selected

5 Extra: Job loss events ‐ permanent and temporary ‐ 48 months Show forest plot

1

Risk Ratio (M‐H, Fixed, 95% CI)

Totals not selected

6 Extra: Sickness absenteeism ‐ Workdays missed as proportion of days worked over the past month ‐ six months Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

Figuras y tablas -
Comparison 1. job loss prevention vs control intervention